D
Damora Therapeutics, Inc.
DMRA · NASDAQ · Healthcare · 1.9B
Closing price
$21.08
+2.53% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.1×
Enterprise value / EBITDAEV/EBITDA
1.1×
Free cash flow yieldFCF yield
-23.4%
Return on equityROE
-87.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.